UBS Maintains Neutral on Gentex, Lowers Price Target to $21
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $24 to $21.
Share
Why It Matters
An analyst thinks Gentex stock is fairly priced but less valuable than before. Watch if the company can improve its business to earn back investor confidence.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.